ENDOMETRIAL CARCINOMA (EC)
Clinical trials for ENDOMETRIAL CARCINOMA (EC) explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CARCINOMA (EC) trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA (EC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets Hard-to-Treat cancers with AKT1 mutation
Disease control OngoingThis early-phase study tests an experimental oral drug, ATV-1601, in adults with advanced solid tumors or certain breast cancers that have a specific AKT1 gene mutation. The main goals are to check the drug's safety, find the best dose, and see how the body processes it. About 13…
Matched conditions: ENDOMETRIAL CARCINOMA (EC)
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated May 26, 2026 12:50 UTC
-
New drug TPST-1495 tested in cancer patients before surgery
Disease control OngoingThis study tests a drug called TPST-1495 in people with endometrial or colorectal cancer who are scheduled for surgery. The goal is to see if the drug can help the immune system fight cancer by looking at blood and tumor samples taken before and after treatment. About 10 adults w…
Matched conditions: ENDOMETRIAL CARCINOMA (EC)
Phase: PHASE2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated May 22, 2026 14:02 UTC